THIS IS WHERE DISCOVERIES ARE BORN!

The Medical University of Białystok obtained the first patent in its history in Canada!

On September 19, 2023, the Canadian Patent Office published information about the granting of a patent for the invention titled: "Derives de L-proline sulfonamide comprenant le systeme pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine, procede de fabrication, utilisations et composition pharmaceutique les comprenant" (,,New L-proline sulfonamide derivatives containing the pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine system, method of their preparation, their uses and pharmaceutical composition containing them”).

The subject of the invention is a method of producing and using a new disulfonamide derivative of triazine (MM-129) in the treatment of gastrointestinal cancer, in particular colorectal cancer.

Scientists from the Medical University of Białystok were involved in the work on obtaining the patent- prof. Dariusz Pawlak, prof. Anna Bielawska, prof. Krzysztof Bielawski, dr hab. Justyna Hermanowicz, dr hab. Anna Tankiewicz-Kwedlo and dr Anna Szymanowska from the Faculty of Pharmacy with the Division of Laboratory Medicine. The co-authors of the invention are also prof. Mariusz Mojzych from the University of Natural Sciences and Humanities in Siedlce and dr Katarzyna Kotwica-Mojzych from the Medical University of Lublin.

Congratulations!